Other conditions of the proposed rule include the following:
• Implementation of the Part D coverage gap discount program.
• Expansion of Part D drug coverage to include benzodiazepines and, for specified health conditions, barbiturates.
• Expansion of benefits for dual-eligible patients.
• Ability for physicians to request reconsiderations with the Independent Review Entity on their patient’s behalf without obtaining a signed authorized representative form if a prescription is denied by a Part D plan.
• Requirement of Part D sponsors to provide, in certain cases, the option of a daily prorated cost-sharing rate for prescriptions for fewer than 30 days.
The proposed rule is open to a 60-day comment period.
Related Articles on CMS Proposed Rules:
HHS Publishes 2 Proposed Rules Regarding Affordable Health Coverage
CMS Issues Final IPPS Rule, Net Medicare Reimbursements to Increase 1.1%
CMS Releases Proposed Standards for CO-OP Insurance Plans
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
